84 related articles for article (PubMed ID: 24815508)
1. Synthesis of isoquinolinone-based tricycles as novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Chen J; Peng H; He J; Huan X; Miao Z; Yang C
Bioorg Med Chem Lett; 2014 Jun; 24(12):2669-73. PubMed ID: 24815508
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of isoindoloisoquinolinone, pyroloisoquinolinone and benzoquinazolinone derivatives as poly(ADP-ribose) polymerase-1 inhibitors.
Suyavaran A; Ramamurthy C; Mareeswaran R; Shanthi YV; Selvakumar J; Mangalaraj S; Kumar MS; Ramanathan CR; Thirunavukkarasu C
Bioorg Med Chem; 2015 Feb; 23(3):488-98. PubMed ID: 25555733
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.
Jagtap PG; Baloglu E; Southan GJ; Mabley JG; Li H; Zhou J; van Duzer J; Salzman AL; Szabó C
J Med Chem; 2005 Aug; 48(16):5100-3. PubMed ID: 16078828
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Rhee HK; Lim SY; Jung MJ; Kwon Y; Kim MH; Choo HY
Bioorg Med Chem; 2009 Nov; 17(21):7537-41. PubMed ID: 19800803
[TBL] [Abstract][Full Text] [Related]
5. 5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2).
Sunderland PT; Woon EC; Dhami A; Bergin AB; Mahon MF; Wood PJ; Jones LA; Tully SR; Lloyd MD; Thompson AS; Javaid H; Martin NM; Threadgill MD
J Med Chem; 2011 Apr; 54(7):2049-59. PubMed ID: 21417348
[TBL] [Abstract][Full Text] [Related]
6. Towards new neuroprotective agents: design and synthesis of 4H-thieno[2,3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitors.
Pellicciari R; Camaioni E; Costantino G; Marinozzi M; Macchiarulo A; Moroni F; Natalini B
Farmaco; 2003 Sep; 58(9):851-8. PubMed ID: 13679179
[TBL] [Abstract][Full Text] [Related]
7. Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia.
Chiarugi A; Meli E; Calvani M; Picca R; Baronti R; Camaioni E; Costantino G; Marinozzi M; Pellegrini-Giampietro DE; Pellicciari R; Moroni F
J Pharmacol Exp Ther; 2003 Jun; 305(3):943-9. PubMed ID: 12606624
[TBL] [Abstract][Full Text] [Related]
8. On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives.
Pellicciari R; Camaioni E; Costantino G; Formentini L; Sabbatini P; Venturoni F; Eren G; Bellocchi D; Chiarugi A; Moroni F
ChemMedChem; 2008 Jun; 3(6):914-23. PubMed ID: 18409175
[TBL] [Abstract][Full Text] [Related]
9. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors.
Gangloff AR; Brown J; de Jong R; Dougan DR; Grimshaw CE; Hixon M; Jennings A; Kamran R; Kiryanov A; O'Connell S; Taylor E; Vu P
Bioorg Med Chem Lett; 2013 Aug; 23(16):4501-5. PubMed ID: 23850199
[TBL] [Abstract][Full Text] [Related]
11. Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure.
Canan Koch SS; Thoresen LH; Tikhe JG; Maegley KA; Almassy RJ; Li J; Yu XH; Zook SE; Kumpf RA; Zhang C; Boritzki TJ; Mansour RN; Zhang KE; Ekker A; Calabrese CR; Curtin NJ; Kyle S; Thomas HD; Wang LZ; Calvert AH; Golding BT; Griffin RJ; Newell DR; Webber SE; Hostomsky Z
J Med Chem; 2002 Nov; 45(23):4961-74. PubMed ID: 12408707
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Wells GJ; Bihovsky R; Hudkins RL; Ator MA; Husten J
Bioorg Med Chem Lett; 2006 Mar; 16(5):1151-5. PubMed ID: 16359865
[TBL] [Abstract][Full Text] [Related]
13. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
[TBL] [Abstract][Full Text] [Related]
14. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
[TBL] [Abstract][Full Text] [Related]
15. Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
Iwashita A; Hattori K; Yamamoto H; Ishida J; Kido Y; Kamijo K; Murano K; Miyake H; Kinoshita T; Warizaya M; Ohkubo M; Matsuoka N; Mutoh S
FEBS Lett; 2005 Feb; 579(6):1389-93. PubMed ID: 15733846
[TBL] [Abstract][Full Text] [Related]
16. Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.
Sakaue M; Mori N; Okazaki M; Ishii M; Inagaki Y; Iino Y; Miyahara K; Yamamoto M; Kumagai T; Hara S; Yamamoto M; Arishima K
J Neurosci Res; 2008 Nov; 86(15):3427-34. PubMed ID: 18627028
[TBL] [Abstract][Full Text] [Related]
17. PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3.
Lindgren AE; Karlberg T; Thorsell AG; Hesse M; Spjut S; Ekblad T; Andersson CD; Pinto AF; Weigelt J; Hottiger MO; Linusson A; Elofsson M; Schüler H
ACS Chem Biol; 2013 Aug; 8(8):1698-703. PubMed ID: 23742272
[TBL] [Abstract][Full Text] [Related]
18. Potent beta-cell protection in vitro by an isoquinolinone-derived PARP inhibitor.
Burkart V; Blaeser K; Kolb H
Horm Metab Res; 1999 Dec; 31(12):641-4. PubMed ID: 10668915
[TBL] [Abstract][Full Text] [Related]
19. A scintillation proximity assay for poly(ADP-ribose) polymerase.
Cheung A; Zhang J
Anal Biochem; 2000 Jun; 282(1):24-8. PubMed ID: 10860495
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
